Navigation Links
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013


76,50176,501Other assets

9,2529,443Total assets

497,790LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

2,863Accrued compensation

8,9528,773Accrued expenses

6,9468,008Accrued clinical trial expenses

24,03217,500Deferred revenue, current portion

23,23921,896Interest payable

3,1677,083Other current liabilities

12,66712,414Total current liabilities

83,22178,537Senior secured notes

125,000125,000Capital lease obligations, less current portion

10,76611,607Liability related to sale of future royalties, less current portion 

122,416128,266Deferred revenue, less current portion

97,91896,551Deferred gain

2,1852,404Other long-term liabilities

9,0158,407Total liabilities

450,521450,772Commitments and contingenciesStockholders' equity:Preferred stock

--Common stock

1111Capital in excess of par value

1,623,2071,617,744Accumulated other comprehensive loss

(395)(357)Accumulated deficit

(1,625,443)(1,570,380)Total stockholders' (deficit) equity

(2,620)47,018Total liabilities and stockholders' equity


(1) The consolidated balance sheet at December 31, 2012 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements.  NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share information)(Unaudited)Three Months Ended

March 31, 20132012Revenue:Product sales 

$  11,810$
,945Royalty revenues 

3253,177Non-cash royalty revenue related to sale of future royalties


SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
4. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
5. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
6. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
9. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
(Date:10/9/2015)... ZURICH, Switzerland , October 9, 2015 ... study with KUR-111 meets primary efficacy endpoint San ... of Orthopaedics and Chief of Orthopaedic Trauma, NYU Lutheran Medical Center, ... San Diego, California , by Dr. Tom ... Lutheran Medical Center, on 9 th October 2015 at 8:30a.m. ...
(Date:10/8/2015)... Calif. , Oct. 8, 2015  "They really ... of her Kaiser Permanente care team, after a ... a treatment plan for cancer. The 79-year-old Kaiser Permanente ... , went in for what she thought was ... her physician and care team, however, she was diagnosed ...
(Date:10/8/2015)...  Following months of investigation, Ross Feller Casey , ... that the anticoagulant Xarelto,s recommended dosage doesn,t work for as ... Philadelphia on behalf of a Florida ... drug didn,t work as the manufacturer suggested. Ross Feller ... on behalf of clients from across the country with similar ...
Breaking Medicine Technology:
... 25, 2011 Ardea Biosciences, Inc. (Nasdaq: RDEA ... from its development program of lesinurad, the Company,s lead product ... at the Annual European Congress of Rheumatology hosted by the ... Results from Primary Dosing Period and ...
... 25, 2011 Sutter Health joins more than a ... Collaborative (HVHC) – a project that will share comparative ... while reducing health care costs across the U.S. ... has made demonstrable improvements in how we deliver health ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... ... to announce it will sponsor the upcoming Cisco Georgia Partner Appreciation Event. The ... on the campus of Georgia Tech, in Atlanta, Georgia. , This year’s partner ...
(Date:10/9/2015)... ... October 09, 2015 , ... OontZ Angle 3 was featured on ... technology products available to consumers. Scott Steinberg, a technology expert and special reporter for ... for students and adventurers. , From Cambridge Soundworks is the OontZ Angle 3. ...
(Date:10/8/2015)... ... October 09, 2015 , ... The Guthrie Sports ... November. The support post-concussion group was started by Steven Hicks, a Licensed Athletic ... The group was started in November 2010 to help support student ...
(Date:10/8/2015)... ... October 08, 2015 , ... ... to commemorate its 15-year anniversary and reveal a new, patient-centered messaging campaign at ... , The conference theme and campaign tagline, “Smarter Research to Unlock Cures,” ...
(Date:10/8/2015)... (PRWEB) , ... October 08, 2015 , ... Florida Hospital, ... year in the team’s Treasure Chests 5K Run/Walk benefitting breast cancer research and patient ... being held on Sunday morning, October 11th at Raymond James Stadium prior to the ...
Breaking Medicine News(10 mins):
... -- Heart rate and blood pressure regulation may hold the ... new study by researchers at Wake Forest Baptist Medical Center, ... orthostatic intolerance (OI), which causes dizziness and occasional fainting when ... chronic nausea in patients., "There seems to be a connection ...
... Mann HealthDay Reporter , WEDNESDAY, Aug. 24 (HealthDay ... United States dropped to 14 percent from 22 percent in ... to be published in the September issue of Obstetrics ... abortion in contemporary America, according to those on both sides ...
... benchmarks representing current critical care practices for ICUs may ... of Massachusetts, the University of Maryland, and Maine Medical ... ICUs and 188 US nonfederal hospitals during 2008. Using ... of these critically ill adults were less than 65 ...
... -- American college students aren,t eating anywhere near the recommended ... finds. In fact, they aren,t even eating one serving ... 582 college students. Males ate about five servings ... four servings per week. Males had more fat in their ...
... has cleared a new diagnostic test that will help save ... with cryptococcosis, a fungal meningitis. The test was developed through ... University of Nevada School of Medicine, and Sean Bauman, president ... rapid blood test known as the CrAg Lateral Flow Assay ...
... , WEDNESDAY, Aug. 24 (HealthDay News) -- Obesity is ... study suggests. In nine states, obesity already accounts for ... according to researchers from RTI International, Duke University and the ... pointed out that taxpayers are footing a large part of ...
Cached Medicine News:
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: